Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-I): impairment of T-cell control of Epstein-Barr virus-infected B-cells.

We have examined the activities of Epstein-Barr virus (EBV)-specific memory T-cells of carriers of adult T-cell leukemia (ATL) associated retrovirus (HTLV-I) and non-carriers in an ATL-endemic area, all of whom were EBV-seropositive, by assay of EBV-induced B-cell focus regression. The result showed that immune suppression, as represented by lowering of the regression, was present in 18 (29%) out of 63 healthy HTLV-I carriers, in contrast to none of 63 matched control persons (healthy non-carriers). This finding suggests that a suppression of cell-mediated immunity is induced by a persistent infection with ATL retrovirus.

[1]  K. Yamaguchi,et al.  Impairment of T-cell control of Epstein-Barr virus infected B-cells in patients with adult T-cell leukemia. , 1986, AIDS research.

[2]  K. Yamaguchi,et al.  HTLV‐I seroprevalence in patients with malignancy , 1986, Cancer.

[3]  M. Bendinelli,et al.  Retrovirus-induced acquired immunodeficiencies. , 1985, Advances in cancer research.

[4]  T. Suchi,et al.  HLA antigens and adult T-cell leukemia virus infection: a community-based study in the Goto Islands, Japan. , 1984, Japanese journal of clinical oncology.

[5]  R. Snyderman,et al.  Immunosuppressive activity of the retroviral envelope protein P 15E and its possible relationship to neoplasia. , 1984, Immunology today.

[6]  K. Nakada,et al.  HIGH INCIDENCE OF HTLV ANTIBODY IN CARRIERS OF STRONGYLOIDES STERCORALIS , 1984, The Lancet.

[7]  K. Sugamura,et al.  Healthy carriers of a human retrovirus, adult T-cell leukemia virus (ATLV): demonstration by clonal culture of ATLV-carrying T cells from peripheral blood. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Kikuchi,et al.  Antibodies to adult t‐cell leukemia‐virus‐associated antigen (atla) in sera from patients with atl and controls in japan: A nation‐wide sero‐epidemiologic study , 1982, International journal of cancer.

[9]  N. Kamada,et al.  A retrovirus associated with human adult T-cell leukemia: in vitro activation. , 1982, Gan.

[10]  J. H. Pope,et al.  Long-term T-cell-mediated immunity to Epstein-Barr virus. , 1981, Cancer research.

[11]  J. H. Pope,et al.  Long‐term T‐cell‐mediated immunity to Epstein‐Barr virus in man. II. Components necessary for regression in virus‐infected leukocyte cultures , 1979 .

[12]  R. Olsen,et al.  Inhibition of human lymphocyte mitogen and antigen response by a 15,000-dalton protein from feline leukemia virus. , 1979, Cancer research.

[13]  J. H. Pope,et al.  Long‐term T‐cell‐mediated immunity to epstein‐barr virus in man. I. Complete regression of virus‐induced transformation in cultures of seropositive donor leukocytes , 1978, International journal of cancer.

[14]  O. Weislow,et al.  Inhibition of lymphocyte transformation by disrupted murine oncornavirus. , 1977, Cancer research.

[15]  E. Hoover,et al.  Active and passive immunization of cats with inactivated feline oncornaviruses. , 1977, Journal of the National Cancer Institute.

[16]  E. Hoover,et al.  Abrogation of resistance to feline oncornavirus disease by immunization with killed feline leukemia virus. , 1977, Cancer research.